Intuitive Surgical, Inc.

Healthcare · Medical - Devices

Overall research band Mixed

Quality Strong

Valuation Very weak

Balance sheet Exceptional

Market confirmation Very weak

One-minute company read

What this report can tell you now

What the company does

Intuitive Surgical, Inc. is a medical technology company that develops, manufactures, and markets advanced tools to enhance patient care, focusing on minimally invasive treatment options. Its primary products include the da Vinci Surgical System, which enables complex surgical procedures with minimal disruption, and the Ion endoluminal system for minimally invasive lung biopsies. The company also offers a range of instruments such as stapling tools, energy devices, and core components, as well as structured training programs and comprehensive customer support services including installation, repairs, and maintenance. Intuitive Surgical serves medical professionals and healthcare institutions in the United States and internationally, generating revenue through the sale of its systems, instruments, and related services.

The current research profile is Premium Growth, with weak market confirmation. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Business quality is the strongest visible dimension. Check valuation before treating that strength as an investment conclusion.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC17.5%Model input; read with the evidence status and period context.

Operating margin29.3%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years15.2%Model input; read with the evidence status and period context.

FCF margin24.7%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.